Mussallem Michael A 的 Form 4 申報
Edwards Lifesciences Corp（EW），2023/5/11 申報
- 申報編號
- 0001225208-23-005754
- 申報時間
- 2023/5/11
- 交易日
- 2023/5/7-5/10
- 申報延遲
- 4 天遲報
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $175.9 萬。交易後 4 天才申報，超過 2 個營業日的期限。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Mussallem Michael ACIK 0001204551 | 董事、高階主管（董事長、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/5/7 | Common Stock | M行使選擇權取得 | +20,777 | $0.00F1 | $0 | 81,724.82 | 直接 | |
| 2023/5/10 | Common Stock | M行使選擇權取得 | +29,375 | $35.20 | +$1,034,000 | 111,099.82 | 直接 | |
| 2023/5/10 | Common Stock | S賣出處分 | −5,984 | $88.94F3 | −$532,216.96 | 105,115.82 | 直接 | |
| 2023/5/10 | Common Stock | G贈與處分 | −9,500 | $0.00 | $0 | 95,615.82 | 直接 | |
| 2023/5/10 | Common Stock | S賣出處分 | −13,891 | $88.29F4 | −$1,226,436.39 | 81,724.82 | 直接 | |
| 2023/5/10 | Common Stock | G贈與取得 | +9,500 | $0.00 | $0 | 3,616,922 | 間接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/5/7 | Common Stock | M行使選擇權處分 | −20,777 | $0.00 | $0 | 5,698 | 直接 | |
| 2023/5/10 | Common Stock | M行使選擇權處分 | −29,375 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $88.84 to $89.25 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $87.83 to $88.83 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
備註
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.